HBV 诱导的 HCC 中的表观遗传重编程与 T 细胞耗竭及其对精准治疗的启示
Epigenetic rewiring and T cell exhaustion in HBV-induced HCC with implications for precision therapies.
肿瘤细胞治疗研究
FRONTIER PAPERS
近 5 年肿瘤细胞治疗领域的研究论文。默认按评分排序(权威性 + 新鲜度)。
Epigenetic rewiring and T cell exhaustion in HBV-induced HCC with implications for precision therapies.
HBV antigen as a tumour antigen in adoptive TCR-T cell therapy for HBV-related HCC: rationale and clinical effectiveness.
A rapid method to assess the in vivo multi-functionality of adoptively transferred engineered TCR T cells.
Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole blood.
Hepatocellular Carcinoma: Current Therapeutic Algorithm for Localized and Advanced Disease.
HBV-HCC treatment with mRNA electroporated HBV-TCR T cells.
Immunological alterations after immunotherapy with short lived HBV-TCR T cells associates with long-term treatment response in HBV-HCC.
共 7 条
MEMBER ACCOUNT
登录成功会直接打开下一页。